Conmed (CNMD) Tops Q1 EPS by 6c, Raises Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St on pace for higher open as oil pulls back ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- S&P Global explores potential separation of Capital IQ business
- Equities end higher as Anthropic's IPO filing buoys AI stocks
CONMED Corporation Announces First Quarter 2023 Financial Results
April 26, 2023 4:05 PM EDTLARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2023.
First Quarter 2023 Highlights
Sales of $295.5 million increased 21.9% year over year as reported and 25.1% in constant currency. Acquisitions contributed approximately 570 basis points of growth. Domestic revenue increased 25.4% year over year. International revenue increased 17.8% year over year as reported and 24.7% in constant currency. Diluted net earnings per share (GAAP) were $0.06, a decrease of 87.2% compared to the first quarter of 2022. Adjusted diluted... More


